Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Active not recruiting 4 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms, Unknown Primary 1

Interventions

Cisplatin 512 Radiotherapy 376 Cyclophosphamide 361 Carboplatin 354 Capecitabine 341 Oxaliplatin 331 Paclitaxel 328 Gemcitabine 318 Docetaxel 314 Fluorouracil 288 Drug Therapy 271 apatinib 245 Bevacizumab 243 camrelizumab 217 Etoposide 200 Irinotecan 182 Doxorubicin 180 Leucovorin 160 Dexamethasone 160 pembrolizumab 150 sintilimab 143 Neoadjuvant Therapy 142 anlotinib 139 Pemetrexed 138 Cytarabine 138 Blood Specimen Collection 138 Surgical Procedures, Operative 130 toripalimab 128 Radiosurgery 127 S 1 (combination) 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × FAPI-46 × Clear all

NCT05263700 2023-03-31

FAPI-CUP

Peter MacCallum Cancer Centre, Australia

Phase NA Unknown

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡